Irinotecan
Active Principle
Irinotecan 40 mg
Irinotecan 100 mg
Presentation
Concentrate for solution for infusion vial 2 ml
Concentrate for solution for infusion vial 5 ml
Indication
Is indicated for the treatment of patients with advanced colorectal carcinoma:
Class
Pharmaceutical product